Total Payments
$5,099
2024 Payments
$767.70
Companies
40
Transactions
311
Medicare Patients
4,161
Medicare Billing
$470,601
Payment Breakdown by Category
Food & Beverage$5,099 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,099 | 311 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $736.15 | 23 | $0 (2024) |
| Daiichi Sankyo Inc. | $435.64 | 20 | $0 (2018) |
| ABBVIE INC. | $411.92 | 26 | $0 (2024) |
| Purdue Pharma L.P. | $409.36 | 34 | $0 (2018) |
| PFIZER INC. | $381.78 | 37 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $369.70 | 19 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $297.02 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $249.80 | 25 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $208.44 | 12 | $0 (2024) |
| Amgen Inc. | $179.75 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $767.70 | 36 | SCILEX PHARMACEUTICALS INC. ($242.99) |
| 2023 | $484.84 | 25 | Almatica Pharma LLC ($108.13) |
| 2022 | $570.43 | 29 | ABBVIE INC. ($163.44) |
| 2021 | $495.45 | 29 | Collegium Pharmaceutical, Inc. ($76.82) |
| 2020 | $216.49 | 15 | Amgen Inc. ($46.61) |
| 2019 | $715.39 | 43 | Boston Scientific Corporation ($215.91) |
| 2018 | $868.73 | 63 | Daiichi Sankyo Inc. ($176.78) |
| 2017 | $980.07 | 71 | Purdue Pharma L.P. ($304.22) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Analgesic | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Opioid Analgesic | ||||||
| 08/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Analgesic | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Gastroenterology | ||||||
| 05/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Analgesic | ||||||
| 04/20/2024 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $42.22 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 04/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $140.33 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/19/2024 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 03/27/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 686 | 1,275 | $430,817 | $80,526 |
| 2022 | 21 | 874 | 2,037 | $398,417 | $98,106 |
| 2021 | 22 | 1,149 | 2,270 | $608,265 | $132,395 |
| 2020 | 29 | 1,452 | 3,705 | $748,490 | $159,574 |
Total Patients
4,161
Total Services
9,287
Medicare Billing
$470,601
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 536 | $77,720 | $43,629 | 56.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $16,412 | $7,550 | 46.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 59 | 72 | $107,800 | $6,760 | 6.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 23 | 38 | $36,100 | $5,223 | 14.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 26 | 46 | $42,687 | $4,210 | 9.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 26 | 46 | $36,774 | $2,410 | 6.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 43 | $4,257 | $2,005 | 47.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 38 | 45 | $37,575 | $1,681 | 4.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 22 | 37 | $17,094 | $1,612 | 9.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 15 | 17 | $10,625 | $1,270 | 11.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 15 | 17 | $12,779 | $1,224 | 9.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 12 | 14 | $3,080 | $1,034 | 33.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 18 | $3,600 | $692.98 | 19.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 28 | 51 | $11,220 | $479.50 | 4.3% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 27 | 44 | $9,680 | $342.76 | 3.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 32 | $1,376 | $299.71 | 21.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 107 | $1,070 | $85.45 | 8.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 21 | 44 | $968.00 | $16.55 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 605 | $87,725 | $47,342 | 54.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 13 | 23 | $21,850 | $6,828 | 31.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 24 | 25 | $42,900 | $5,923 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $9,898 | $5,351 | 54.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 16 | 27 | $24,769 | $4,500 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 67 | $6,633 | $3,867 | 58.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 13 | 23 | $10,626 | $3,673 | 34.6% |
About Dr. Don Smith, MD
Dr. Don Smith, MD is a Pain Medicine healthcare provider based in Cordele, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053329268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Don Smith, MD has received a total of $5,099 in payments from pharmaceutical and medical device companies, with $767.70 received in 2024. These payments were reported across 311 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,099).
As a Medicare-enrolled provider, Smith has provided services to 4,161 Medicare beneficiaries, totaling 9,287 services with total Medicare billing of $470,601. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology
- Location Cordele, GA
- Active Since 08/03/2006
- Last Updated 04/07/2021
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1053329268
Products in Payments
- ZTLido (Drug) $314.83
- XTAMPZA (Drug) $283.58
- Movantik (Drug) $281.95
- QULIPTA (Drug) $280.94
- Amitiza (Drug) $260.45
- LYRICA (Drug) $228.25
- Morphabond ER (Drug) $213.85
- SYMPROIC (Drug) $208.84
- GENERAL PAIN MANAGEMENT (Device) $199.48
- RELISTOR (Drug) $194.48
- Aimovig (Biological) $179.75
- GRALISE (Drug) $165.90
- UBRELVY (Drug) $147.75
- AJOVY (Drug) $138.55
- EMGALITY (Drug) $132.95
- NURTEC ODT (Drug) $121.71
- SPECTRA WAVEWRITER (Device) $120.07
- HYSINGLA ER (Drug) $112.40
- AIMOVIG (Biological) $92.12
- MONOVISC (Device) $78.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.